Dr. Jamal A. Khan, MBBS MD

Profile

Dr. Jamal A. Khan has been a researcher and teaching faculty at the Jawaharlal Nehru Medical College at Aligarh Muslim University, from 1997 till 2005. He left his job to pursue his research interest in immunology and more particularly, cancer. He set out to develop a treatment modality for cancer patients based on revival of immunology.

He set up his clinic in Noida, in 2005 and began to work in cancer immunotherapy, using patient’s own immune cells. With the ethical committee’s permission to start treatment, a press meet was organized to inform patients. Only advanced disease patients, who had exploited all means of treatment and resistant to conventional therapy, were enrolled for the customized immunotherapy plan. Because of the autologous nature of the therapy, few to negligible side effects were observed. The treatment proved to be useful in improving quality life for the advanced stage patients, and became a good treatment modality in palliation. Gradually, observing the safety and efficacy of the therapy over a period of years, early stage patients were also advised to help prevent relapse and improve survival.

He set up the company, Institute of Cellular Therapies along with his wife Dr. Sharmin Yaqin, in 2007. He named the therapy Denvax, based on the nature of cells used to generate robust immunity, the dendritic cells. Dendritic cells are cells of the immune system which have the key role of antigen presentation. They help in passing the vital information of killing the cancer cells, to T-cells, the effector cells of the immune system. In cancer, it is this link of passing the information that is missing, and that is why the disease.

Dr. Khan also developed a method to collect and store the patient’s blood for long hours preserving their viability for 19 hours. This nutritional medium is called CellNute, used to collect blood for patients who are distantly located.

Dr. Khan is also working in diabetes using mesenchymal stem cells derived from the cord blood as a trial therapy.

Till date, he has treated over a thousand patients suffering from various types of solid tumors, in different stages of the disease. He has published two case reports attached herewith, available online on PubMed. These are the first hits in Google online search from the year 2006 till date.

He chaired scientific session on Cancer Immunotherapy in World Cancer Congress, Geneva in August 2008. He has also presented papers in ICON Mumbai, September 2009, and The Indian Cancer Congress, Bhubaneshwar, 2011.

He also spoke on Cell Therapies, at the Indian Medical Tourism Destination, Africa 2011, held in Nairobi, Kenya, on March 17-18th.

Dr. Khan has recently attended the 102^nd Annual Meeting of American Association of Cancer Research: Innovation and Collaboration- the path to success, in Orlando Florida, USA, held on April 2-6^th 2011. 

Dr. Jamal A. Khan is a pioneer in cancer immunotherapy in India, with over seven years of exclusive clinical experience in dendritic cell therapy. His work on dendritic cell therapy in treating cancer is unparalleled in India.

Currently, he is an active member of the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR) and the Indian Medical Association.

Email: jamal@dendriticcellresearch.com

Contact: 0091 98911 62601, 0091 99100 55863

Prof.(Dr.) Vasant R. Pai

Chief Consultant Medical Oncology

Prof. V. R. Pai is a renowned Medical Oncologist formerly at Tata Memorial Hospital, Mumbai. Prof. Pai is having more than 32 years of experience as Professor and consultant- Medical Oncology at TATA Memorial Hospital with significant achievements in developing cancer care and management strategies, training medical staff and publication of  various articles in many national and international journals. 

Email: drvrpai@rediffmail.com

Contact: 0091 98211 89764

Dr. Sharmin Yaqin

Director, ICT Pvt. Ltd.

Email sharmin@dendriticcellresearch.com

Dr. Yaqin is an MBBS and MD in Medical Biochemistry from Jawaharlal Nehru Medical College, AMU, Aligarh. Soon after her MD she joined Microbiology Research Lab as consultant Biochemist. Her research interest lies in cell culture and tumor biology. She is a certified post graduate in clinical research and data management. She also holds certificate on Advanced GCP.

For the last 5 years she is working at promoting and developing Denvax cell therapy, at the Institute of Cellular Therapies Pvt. Ltd.

She is also the co-author of two case reports on dendritic cell therapy.

She is the active member of International Society for Dendritic Cell and Vaccine Science.

Email: sharmin@dendriticcellresearch.com

Contact: 0091 99118 62601

We are a team of medical and allied professionals, devoted to cancer care for many years. The Institute of Cellular Therapies Pvt. Ltd. was established in the year 2006 and since then is actively engaged in administering safe and effective dendritic cell treatment to numerous cancer patients. The idea is to make the treatment affordable and accessible to a large patient population. Greater number of patients should be benefited from high quality meaningful research.